Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cromodata

Explore full profile

Secure Real World Data platform for healthcare

Buenos Aires, ArgentinaFounded 2023Health Tech & Medtech
Valuation $5–10M Last recorded · 2025
Headcount <100 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cromodata and the history behind them.

About Cromodata

Cromodata is an Argentine healthtech startup that has developed a collaborative platform to structure and anonymize clinical information from hospitals and diagnostic centers across Latin America. The company was founded by Keila Barral Masri (CEO), Matías Karlsson (CTO), and Juan Pablo Merea (COO). The inspiration for Cromodata came from CEO Keila Barral Masri's personal seven-year journey to receive a diagnosis for a medical condition, which she realized was due to her health data being fragmented across different providers. This experience, shared by other team members who are also patients, fuels the company's mission to connect health data for timely diagnoses.

The platform addresses the underrepresentation of Latin American data in global healthcare AI development, where it currently accounts for less than 1%. Cromodata connects data generators, such as clinics and hospitals, with data consumers like pharmaceutical companies, tech innovators, and researchers. The business model involves monetizing the anonymized data, which provides a new revenue stream for healthcare institutions and gives data consumers access to high-quality, diverse datasets for training AI models and accelerating research. Cromodata charges a fee for sourcing, anonymizing, securing, and linking the data between parties. The company's technology ensures data is encrypted and anonymized at the source, complying with international privacy standards like HIPAA, GDPR, and ISO 27001. This allows for the tokenization of patient identities, enabling the linking of records from different institutions without revealing personal information.

As of October 2025, Cromodata works with 47 hospitals across five countries—Argentina, Brazil, Uruguay, the Dominican Republic, and Mexico—and has processed over 20 million anonymized patient records. The company recently closed a pre-seed funding round of $1.2 million, led by PharmStars Ventures, a fund backed by major pharmaceutical companies including Pfizer and Roche. This investment will support its expansion and efforts to build a comprehensive health data ecosystem for the region.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
Buenos Aires, Argentina
Employees
15
Open positions
None listed
Dealroom signal
72.9/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Medical Data, Privacy-Enhancing Technologies
Business model
SaaS
Client focus
b2b

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Oct 2025 $1.2M $4.8M Sands Capital Management · Maria Gabriela Pittis · PharmStars Ventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Cromodata website traffic

Latest recorded traffic for Cromodata is 310 monthly website visits, up 520% over the last three months. Cromodata's team grew 150% over the past year.

Latest monthly visits310 3-month web change+520% 1-year team growth+150%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • PharmStars Ventures
  • Sands Capital Management
  • Maria Gabriela Pittis
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇦🇷 Argentina60%
🇨🇴 Colombia20%
🇪🇸 Spain13.3%
🇲🇽 Mexico6.7%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cromodata on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cromodata’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.